Let's get digital
What happens when forty researchers, patients, entrepreneurs and health and social care staff come together to discuss digital technologies and their impact on NHS sustainability and transformation?
That was the experiment at the University of Southampton' s Web Sciences Institute on 16 January, at a workshop sponsored by the Institute, the CLAHRC and Wessex AHSN.
And the result?
A highly energetic and constructive exchange of views from the diverse stakeholders in the room.
The take away messages:
1. The NHS has to embrace digital technologies to survive but precisely how it embraces these is critical;
2. successful adoption of digital technologies needs to take account of:
• the political imperative of developing a compact between public services, service providers and citizens about how their data may be used;
• the social processes involved in patient and workforce adaption to technologies and the substantial research base that already exists in this field *the technical challenges involved in ensuring that a proliferation of health data and digital devices develops in a way that supports integrated, patient-centred care rather than promoting fragmented data and digital silos;
• developing the capacity to adapt to and exploit fundamentally disruptive innovation from within the NHS and from SMEs many of which have their origins in academic research or front-line clinical practice
Next steps?
How might we maintain and develop the coalition of interests that met in the workshop to underpin a research-driven, innovation-friendly digital technologies implementation plan for the NHS in Hampshire and the Isle of Wight. Watch this space.
The AHSN and Centre for Implementation Science is working as the independent evaluator for the Happy, Healthy, at Home Vanguard programme in North East Hampshire and Farnham.
This was the second symposium of the independent evaluation and focused on the Farnham Locality. The event included presentations from the Farnham Integrated Care Team and the Farnham Referral Management Service, as well as a series of ‘Evaluation Stations’ where delegates spent time with teams from Farnham, North East Hampshire and Farnham CCG and NHS England.
The event was attended by a wide-range of people who are interested in seeing how the vanguard programme is making changes to the local health system in North East Hampshire and Farnham and who are interested in evaluation approaches. These are the collected slides from the day.
This is our Business Plan for the next year; 2017-18.
In health, as in other sectors, innovation and adoption at scale is increasingly driven by interdisciplinary research, synergies between industries, and a step-change in end-user (citizen, consumer, patient) engagement in the process. Seeing the wood from the trees, making connections, spotting opportunities, and understanding how to get traction requires a breadth of perspective and strong roots into, and across, that landscape.
Academic Health Science Networks (AHSNs) connect horizontally across research, industries, commissioners, providers and users; and network vertically between policy formulation, system design, operational coal-face and end-user experience. That role takes us across all parts of the NHS, into industry, local government and other public agencies, into universities, charities, start-ups, and into funders. And up and down the system; from the role of the GP receptionist in improvement and innovation; to dialogue with policy makers and regulators about refining system design to support adoption and spread of innovation.
Networks which are open to, and embrace, the diverse perspectives of these stakeholders will, in turn, help the systems and members which they support be open to the adoption and spread of innovation.
That is what we, Wessex AHSN, aspire to. We hope you find this spirit reflected in our business plan.
How is quality faring? Priorities and impact on the frontlineQualityWatch
A presentation given to the QualityWatch 2015 annual conference by Professor Tim Evans, Medical Director and Responsible Officer, Royal Brompton and Harefield NHS Foundation Trust.
Let's get digital
What happens when forty researchers, patients, entrepreneurs and health and social care staff come together to discuss digital technologies and their impact on NHS sustainability and transformation?
That was the experiment at the University of Southampton' s Web Sciences Institute on 16 January, at a workshop sponsored by the Institute, the CLAHRC and Wessex AHSN.
And the result?
A highly energetic and constructive exchange of views from the diverse stakeholders in the room.
The take away messages:
1. The NHS has to embrace digital technologies to survive but precisely how it embraces these is critical;
2. successful adoption of digital technologies needs to take account of:
• the political imperative of developing a compact between public services, service providers and citizens about how their data may be used;
• the social processes involved in patient and workforce adaption to technologies and the substantial research base that already exists in this field *the technical challenges involved in ensuring that a proliferation of health data and digital devices develops in a way that supports integrated, patient-centred care rather than promoting fragmented data and digital silos;
• developing the capacity to adapt to and exploit fundamentally disruptive innovation from within the NHS and from SMEs many of which have their origins in academic research or front-line clinical practice
Next steps?
How might we maintain and develop the coalition of interests that met in the workshop to underpin a research-driven, innovation-friendly digital technologies implementation plan for the NHS in Hampshire and the Isle of Wight. Watch this space.
The AHSN and Centre for Implementation Science is working as the independent evaluator for the Happy, Healthy, at Home Vanguard programme in North East Hampshire and Farnham.
This was the second symposium of the independent evaluation and focused on the Farnham Locality. The event included presentations from the Farnham Integrated Care Team and the Farnham Referral Management Service, as well as a series of ‘Evaluation Stations’ where delegates spent time with teams from Farnham, North East Hampshire and Farnham CCG and NHS England.
The event was attended by a wide-range of people who are interested in seeing how the vanguard programme is making changes to the local health system in North East Hampshire and Farnham and who are interested in evaluation approaches. These are the collected slides from the day.
This is our Business Plan for the next year; 2017-18.
In health, as in other sectors, innovation and adoption at scale is increasingly driven by interdisciplinary research, synergies between industries, and a step-change in end-user (citizen, consumer, patient) engagement in the process. Seeing the wood from the trees, making connections, spotting opportunities, and understanding how to get traction requires a breadth of perspective and strong roots into, and across, that landscape.
Academic Health Science Networks (AHSNs) connect horizontally across research, industries, commissioners, providers and users; and network vertically between policy formulation, system design, operational coal-face and end-user experience. That role takes us across all parts of the NHS, into industry, local government and other public agencies, into universities, charities, start-ups, and into funders. And up and down the system; from the role of the GP receptionist in improvement and innovation; to dialogue with policy makers and regulators about refining system design to support adoption and spread of innovation.
Networks which are open to, and embrace, the diverse perspectives of these stakeholders will, in turn, help the systems and members which they support be open to the adoption and spread of innovation.
That is what we, Wessex AHSN, aspire to. We hope you find this spirit reflected in our business plan.
How is quality faring? Priorities and impact on the frontlineQualityWatch
A presentation given to the QualityWatch 2015 annual conference by Professor Tim Evans, Medical Director and Responsible Officer, Royal Brompton and Harefield NHS Foundation Trust.
Anticipatory Care Planning: Time To Make It Happen - Early Intervention Using The Life curve Dr Sarah Mitchell (Programme Manager - AHP National Delivery Plan)
A feasibility study to examine the adoption of CBT techniques and their impact on clinical practice in the community pharmacy environment
Led by the AHSN Network
Day One, Pop-up University 8, 11.00
BILD Event – 21 March 2018 : Transforming care - Sharing solutions that make ...NHS England
Stream E – Clinical leadership: using dynamic risk registers to prevent admissions and Care and Treatment Reviews to facilitate discharge
Dr Roger Banks and Dr Salim Razak discuss clinical leadership and clinical culture and the dynamic process for risk stratification before describing C(E)TRs, their outcomes so far and their role in achieving successful discharge into the community.
Advancing Team-Based Care:Data Driven Dashboards to Support Team Based Care CHC Connecticut
This webinar highlighted the ways that practices utilize technology to improve individual patient care and track and meet the needs of their whole patient population. By using electronic health record data and clinical dashboards, members of the team can organize visits to resolve care gaps, optimize prevention, and improve clinical outcomes.
This webinar was presented April 7, 2016 3:00 PM Eastern Time
Advancing Team-Based Care: A Team Approach to Prevention and Chronic Illness ...CHC Connecticut
This webinar explored the benefits of teamwork in allowing staff to more effectively deliver preventive services and manage chronic illness. It built on the content from previous webinars to describe how to optimize the core team to provide population management, self-management support and planned care. Infrastructure considerations to improve team-based care were also discussed including training, career ladders, and communication management.
This webinar was present April 21, 2016 3:00 PM.
Advancing Team-Based Care: Complex Care Management in Primary CareCHC Connecticut
This webinar investigated the ways that team members can contribute to the care of patients with complex medical and/or social needs. The focus was on developing the expanded care team and ensuring ready communication between the core and expanded care teams. Models for effective care management were presented.
This webinar was presented May 5, 2016 3:00 p.m. Eastern Time
Anticipatory Care Planning: Time To Make It Happen - Early Intervention Using The Life curve Dr Sarah Mitchell (Programme Manager - AHP National Delivery Plan)
A feasibility study to examine the adoption of CBT techniques and their impact on clinical practice in the community pharmacy environment
Led by the AHSN Network
Day One, Pop-up University 8, 11.00
BILD Event – 21 March 2018 : Transforming care - Sharing solutions that make ...NHS England
Stream E – Clinical leadership: using dynamic risk registers to prevent admissions and Care and Treatment Reviews to facilitate discharge
Dr Roger Banks and Dr Salim Razak discuss clinical leadership and clinical culture and the dynamic process for risk stratification before describing C(E)TRs, their outcomes so far and their role in achieving successful discharge into the community.
Advancing Team-Based Care:Data Driven Dashboards to Support Team Based Care CHC Connecticut
This webinar highlighted the ways that practices utilize technology to improve individual patient care and track and meet the needs of their whole patient population. By using electronic health record data and clinical dashboards, members of the team can organize visits to resolve care gaps, optimize prevention, and improve clinical outcomes.
This webinar was presented April 7, 2016 3:00 PM Eastern Time
Advancing Team-Based Care: A Team Approach to Prevention and Chronic Illness ...CHC Connecticut
This webinar explored the benefits of teamwork in allowing staff to more effectively deliver preventive services and manage chronic illness. It built on the content from previous webinars to describe how to optimize the core team to provide population management, self-management support and planned care. Infrastructure considerations to improve team-based care were also discussed including training, career ladders, and communication management.
This webinar was present April 21, 2016 3:00 PM.
Advancing Team-Based Care: Complex Care Management in Primary CareCHC Connecticut
This webinar investigated the ways that team members can contribute to the care of patients with complex medical and/or social needs. The focus was on developing the expanded care team and ensuring ready communication between the core and expanded care teams. Models for effective care management were presented.
This webinar was presented May 5, 2016 3:00 p.m. Eastern Time
iFlashLED is controller for LED lights which can be controllable with smart phones, computer application or WEB interface in browser. Real Time Cable and Wi-Fi controllable, Universal Power Supply 8-16V, Max 100 PCB with LEDs in conjunction, PIR Sensors, Programmable user programs and settings, Wi-Fi Secure Control with WPA, WEP Encryption, iPhone / iPod Touch / iPad Controller App, Open UDP - TCP Protocol, Auto Start function and all settings are stored, WEB Interface.
İnovatif Kimya Dergisi Sayı-22 Anlatılan Konu Başlıkları
Kırmızı Savaşçı Likopen
Osmanlılarda Kimyasal Maddelerin İsimlendirilmesi
Doğanın Mucize Molekülleri Fenolik Bileşikler
Kenetlenme Reaksiyonlarında Homojen Katalizörler
Serotonin’in Akrabası Dopamin
Verim Hesabı
Fullerenler
PolyMath ve Kimya Mühendisliği
Ayrıca Her Ay 3 Web Sitesi ve Kimya Bulmacası, Kimya Sektöründen Haberler, Kimya Sözlüğü ile Element Tanıyalım
İyi okumalar dileriz.
İnovatif Kimya Dergisi Sayı-24 Anlatılan Konu Başlıkları
Kiralite ve Talidomid Faciası
Gliserol
Akış Şemaları
Çamaşır Suyu
Ayrıca Her Ay 3 Web Sitesi ve Kimya Bulmacası, Kimya Sektöründen Haberler, Kimya Sözlüğü ile Element Tanıyalım
İyi okumalar dileriz.
A growth-oriented professional, excels in devising & implementing strategies to ensure attainment of profit targets & business goal.
"High ambitions and strong will power.I am interested in new assignments,
" Grooming the team up to the mark of management keep an eye on competitors activity's, seeking senior level assignments in Channel Management.
TYA and Adult Late Effects Service at UCLHUCLPartners
Presentation by Victoria Grandage of University College London Hospitals NHS Foundation Trust at the London Cancer Children, Teenager and Young Adults Study Day, held on 25 July 2013.
Two of the New York metro area’s largest provider organizations will share their experiences leveraging HIE as one of many tools to decrease fragmentation of care and improve patients’ experiences across acute and post-acute care settings for patients undergoing elective surgeries. Representatives from NYULMC and VNSNY will summarize their efforts to redesign more personalized specific care pathways and the central role played by the implementation of real-time data exchange to provide a seamless transfer of clinical data between providers caring for the patient at the time of discharge and throughout the post-acute period.
• Kathleen Mullaly - Senior Director for Clinical Operations, Department of Network Integration, NYU Langone Medical Center
• Amy Weiss - Director for Strategic Account Development, Integrated Delivery Systems, Visiting Nurse Service of New York (VNSNY)
New York eHealth Collaborative Digital Health Conference
November 18, 2014
Presentation made by Celia Ingham Clark National Director for Reducing Premature Mortality, at Improving access to seven day services. Southampton 25 March 2015
Kings Road Medical Centre rated Outstanding by Care Quality Commissionatmedics
AT Medics is a leading provider of Primary Healthcare services in London and recently achieved an “Outstanding” Care Quality Commission (CQC) rating for Kings Road Medical Centre, making it one of only seven practices in London to achieve this distinguished accolade under the CQCs new inspection approach. Nationally, just 84 practices have been rated as “Outstanding”.
Using simulation to drive changes in health and care - long term conditions Year of Care model
Bev Matthews and Claire Cordeaux
Presentation from Day 1 of the Health and Care Innovation Expo 2014, Manchester Central
Making Seven Day Services a reality, pop up uni, 2 pm, 3 september 2015NHS England
Expo is the most significant annual health and social care event in the calendar, uniting more NHS and care leaders, commissioners, clinicians, voluntary sector partners, innovators and media than any other health and care event.
Expo 15 returned to Manchester and was hosted once again by NHS England. Around 5000 people a day from health and care, the voluntary sector, local government, and industry joined together at Manchester Central Convention Centre for two packed days of speakers, workshops, exhibitions and professional development.
This year, Expo was more relevant and engaging than ever before, happening within the first 100 days of the new Government, and almost 12 months after the publication of the NHS Five Year Forward View. It was also a great opportunity to check on and learn from the progress of Greater Manchester as the area prepares to take over a £6 billion devolved health and social care budget, pledging to integrate hospital, community, primary and social care and vastly improve health and well-being.
More information is available online: www.expo.nhs.uk
Jacquie White, Deputy Director of NHS England Long Term Conditions, Older People & End of Life Care and Dr Eileen Pepler, Academic, Researcher and Consultant in the Canadian Healthcare will discuss how NHS England work in chronic disease is being translated into a Canadian context.
Cheryl Davenport, Director of Health and Care Integration at Leicestershire County Council, talks about how simulation is helping to evaluate how emergency hospital admissions can be reduced.
New Care Models - the story so far, pop up uni, 2pm, 3 september 2015NHS England
Expo is the most significant annual health and social care event in the calendar, uniting more NHS and care leaders, commissioners, clinicians, voluntary sector partners, innovators and media than any other health and care event.
Expo 15 returned to Manchester and was hosted once again by NHS England. Around 5000 people a day from health and care, the voluntary sector, local government, and industry joined together at Manchester Central Convention Centre for two packed days of speakers, workshops, exhibitions and professional development.
This year, Expo was more relevant and engaging than ever before, happening within the first 100 days of the new Government, and almost 12 months after the publication of the NHS Five Year Forward View. It was also a great opportunity to check on and learn from the progress of Greater Manchester as the area prepares to take over a £6 billion devolved health and social care budget, pledging to integrate hospital, community, primary and social care and vastly improve health and well-being.
More information is available online: www.expo.nhs.uk
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Reducing opioid prescribing, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Pharmacist Interventions and Medication Reviews at Care Homes - Improving Med...Health Innovation Wessex
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Pharmacist Interventions and Medication Reviews at Care Homes - Improving Medication Safety and Patient Outcomes, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, SBAR Patient Engagement Tool, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Reducing medication related falls risk in patients with severe frailty, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Assessing the outcomes of structured medication reviews, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Polypharmacy SMR reviews in outpatient bone health clinics, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Polypharmacy reviews of asthma and COPD patients over 65 and 10 or more medic...Health Innovation Wessex
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Polypharmacy reviews of asthma and COPD patients over 65 and 10 or more medicines, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Evaluating the impact of a specialist frailty multidisciplinary team pathway ...Health Innovation Wessex
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Evaluating the impact of a specialist frailty multidisciplinary team pathway with clinical pharmacist involvement, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Genome UK – State of the nation by Professor Dame Sue Hill, Chief Scientific Officer for England and NHS Genomics Programme Senior Responsible Officer.
Pharmacogenomics into practice - stroke services and a systems approach by Dr Richard Marigold, Consultant Stroke Physician and NIHR Hyperacute Stroke Research Centre Lead, University Hospital Southampton NHS Foundation Trust
To evaluate the benefits of Structured Medication Reviews in elderly Chinese ...Health Innovation Wessex
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, To evaluate the benefits of Structured Medication Reviews in elderly Chinese patients, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary,
Review of patients on high dose opioids at Living Well PCN, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Re-establishing autonomy in elderly frail patients, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Improving Medication Reviews using the NO TEARS Tool, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Improving care in County Durham under the STOMP agenda - A 5 year review.pdfHealth Innovation Wessex
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Improving care in County Durham under the STOMP agenda - A 5 year review, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Impact of an EMIS search to prioritise care home residents for a pharmacist l...Health Innovation Wessex
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Impact of an EMIS search to prioritise care home residents for a pharmacist led medication review, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Identifying Orthostatic Hypotension caused by Medication, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
2. • In 2015/16 West Hampshire CCG used its
Transformation Funding with its four GP
Federations to design and deliver transformation
projects for older people:
• Eastleigh Southern Parishes Network – Care
Navigators
• Mid Hampshire Healthcare – Proactive Care
Teams
• New Forest Healthcare – Care Navigators
• Tri-Locality Care - Practice Based Outreach Teams
Transformation Fund Projects
3. AHSN Evaluation
The CCG commissioned Wessex AHSN to evaluate
each of these. Evaluations included:
• Implementation and organisation
• Service statistics
• Surveys of stakeholders and referrers
• Patient Reported Outcome Measures
• Case studies
• Impact on emergency secondary care activity
• Economic evaluation
5. Comparison
Issues
• Different patient groups
• Different length of time support/ care
provided
• Assumptions about how long the benefits last
and how these might differ
6. Transformation Fund Evaluation Summaries
Eastleigh Southern Parishes Network Care
Navigators
Mid Hampshire Healthcare Proactive Care
Teams
New Forest Healthcare Limited Care
Navigators
Population · 49,000 people
· 5 general practices
· 205,000 people
· 19 general practices
· 189,000 people
· 17 general practices
Service The service started seeing patients in August
2015.
5 fte Care Navigators (CNs) (band 4
equivalent) attached to practices and
providing cross cover and a 7 day service.
Service primarily for older vulnerable patients
- who are contacted within 24 hours of
referral; visited at home and a holistic plan
developed covering care coordination and
connection with voluntary sector. CN
implements plan with patient/ carer. Patients
are supported as long as is required and
average is 6.5 weeks.
45% of referrals come from GPs and 45%
from reviewing hospital discharges for over
70’s.
The service started seeing patients in October
2015.
12.4 fte Proactive Care Nurses (PCNs) (band 6
equivalent) and 6.7 fte Care Coordinators
(CCs) (band 4 equivalent) appointed to provide
a 5 day service to people aged over 70 who are
identified as being at risk of deterioration or
crisis
PCNs undertake an initial 40 minute home visit
and holistic assessment from which they
develop a plan that will involve social
prescribing and referral to health and care
services. They can also provide direct clinical
care such as phlebotomy and falls
assessments. Patients typically receive 2 visits.
CC’s are based in the practice and work in
partnership with the PCNs to maintain contact
with patients and to take the actions to deliver
the plan.
The service started seeing patients in October
2015.
9.4 fte Care Navigators (CNs) (band 4
equivalent) attached to practices providing a 5
day service to people aged over 70 requiring
support and signposting.
The CNs provide a short period of active support
these patients typically over a 2-4 week period.
Half will receive a phonecall and half will be
visited at home – to establish which social,
voluntary and health services might help them
and to signpost them to these.
60% of referrals from GPs with the remainder
coming from a wide range of sources within the
practice and from other services.
Patient numbers Receive an average of 62 new referrals
per month – approx. 12 per CN.
Estimate annual activity 744 patients.
See 391 new patients per month –
approx.. 31 per PCN.
Estimate annual activity 4692 patients
Receive an average of 238 new referrals per
month – approx. 25 per CN.
Estimate annual activity 1500 patients.
Activity impact1
Analysis of 183 patients showed:
· A&E attendances reduced by 50%
· NEL admissions reduced by 32%
Analysis of 1757 patients showed:
· A&E attendances reduced by 31%
· NEL admissions reduced by 32%
· Ambulance activity reduced by 12%
Analysis of 1018 patients showed:
· A&E attendances reduced by 46%
· NEL admissions reduced by 20%
Economic
evaluation
(In development)
· Extrapolating the activity reductions to
all patients and over a year identified
potential tariff savings of £627,000.
· Potential Return on Investment 225%
· Extrapolating the activity reductions to
all patients and over a year identified
potential tariff savings of £2,715,000
· Potential Return on Investment 222%.
1
The analysis for Eastleigh and New Forest compared activity for the 120 days before referral with the 120 days afterwards. For Mid Hampshire it compared 90 days.
7. R-Outcomes scores from Eastleigh Southern Parishes and Mid Hampshire Healthcare
The higher the score –
the more positive the
response from patients